Literature DB >> 24469240

Partial deletions of the GRN gene are a cause of frontotemporal lobar degeneration.

Fabienne Clot1, Anne Rovelet-Lecrux, Foudil Lamari, Sandrine Noël, Boris Keren, Agnès Camuzat, Agnès Michon, Ludmila Jornea, Béatrice Laudier, Anne de Septenville, Paola Caroppo, Dominique Campion, Cécile Cazeneuve, Alexis Brice, Eric LeGuern, Isabelle Le Ber.   

Abstract

Mutations in the progranulin gene (GRN) are an important cause of frontotemporal lobar degeneration (FTLD). Most known GRN mutations are null mutations, such as nonsense and frameshift mutations, which create a premature stop codon resulting in loss of function of the progranulin protein. Complete or near-complete genomic GRN deletions have also been found in three families, but heterozygous partial deletions that remove only one or two exons have not been reported to date. In this study, we analysed three unrelated FTLD patients with low plasma progranulin levels but no point GRN mutations by multiplex ligation-dependent probe amplification (MLPA) and quantitative multiplex polymerase chain reaction of short fluorescent fragments (QMPSF). We detected two heterozygous partial GRN deletions in two patients. One deletion removed exon 1 and part of intron 1. The second deletion was complex: it removed 1,410 bp extending from the part of intron 1 to the part of exon 3, with a small 5-bp insertion at the breakpoint junction (c.-7-1121_159delinsGATCA). Our findings illustrate the usefulness of a quantitative analysis in addition to GRN gene sequencing for a comprehensive genetic diagnosis of FTLD, particularly in patients with low plasma progranulin levels.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24469240     DOI: 10.1007/s10048-014-0389-x

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  17 in total

Review 1.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.

Authors:  D Neary; J S Snowden; L Gustafson; U Passant; D Stuss; S Black; M Freedman; A Kertesz; P H Robert; M Albert; K Boone; B L Miller; J Cummings; D F Benson
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

2.  Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: a multicenter Italian study.

Authors:  Roberta Ghidoni; Elena Stoppani; Giacomina Rossi; Elena Piccoli; Valentina Albertini; Anna Paterlini; Michela Glionna; Eleonora Pegoiani; Luigi F Agnati; Chiara Fenoglio; Elio Scarpini; Daniela Galimberti; Michela Morbin; Fabrizio Tagliavini; Giuliano Binetti; Luisa Benussi
Journal:  Neurodegener Dis       Date:  2011-11-26       Impact factor: 2.977

3.  Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia.

Authors:  Basar Cenik; Chantelle F Sephton; Colleen M Dewey; Xunde Xian; Shuguang Wei; Kimberley Yu; Wenze Niu; Giovanni Coppola; Sarah E Coughlin; Suzee E Lee; Daniel R Dries; Sandra Almeida; Daniel H Geschwind; Fen-Biao Gao; Bruce L Miller; Robert V Farese; Bruce A Posner; Gang Yu; Joachim Herz
Journal:  J Biol Chem       Date:  2011-03-23       Impact factor: 5.157

4.  Progranulin null mutations in both sporadic and familial frontotemporal dementia.

Authors:  Isabelle Le Ber; Julie van der Zee; Didier Hannequin; Ilse Gijselinck; Dominique Campion; Michèle Puel; Annie Laquerrière; Tim De Pooter; Agnès Camuzat; Marleen Van den Broeck; Bruno Dubois; François Sellal; Lucette Lacomblez; Martine Vercelletto; Catherine Thomas-Antérion; Bernard-François Michel; Véronique Golfier; Mira Didic; François Salachas; Charles Duyckaerts; Marc Cruts; Patrice Verpillat; Christine Van Broeckhoven; Alexis Brice
Journal:  Hum Mutat       Date:  2007-09       Impact factor: 4.878

5.  Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21.

Authors:  Marc Cruts; Ilse Gijselinck; Julie van der Zee; Sebastiaan Engelborghs; Hans Wils; Daniel Pirici; Rosa Rademakers; Rik Vandenberghe; Bart Dermaut; Jean-Jacques Martin; Cornelia van Duijn; Karin Peeters; Raf Sciot; Patrick Santens; Tim De Pooter; Maria Mattheijssens; Marleen Van den Broeck; Ivy Cuijt; Krist'l Vennekens; Peter P De Deyn; Samir Kumar-Singh; Christine Van Broeckhoven
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

6.  Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration.

Authors:  R Ghidoni; L Benussi; M Glionna; M Franzoni; G Binetti
Journal:  Neurology       Date:  2008-09-03       Impact factor: 9.910

7.  Deletion of the progranulin gene in patients with frontotemporal lobar degeneration or Parkinson disease.

Authors:  Anne Rovelet-Lecrux; Vincent Deramecourt; Solenn Legallic; Claude-Alain Maurage; Isabelle Le Ber; Alexis Brice; Jean-Charles Lambert; Thierry Frébourg; Didier Hannequin; Florence Pasquier; Dominique Campion
Journal:  Neurobiol Dis       Date:  2008-04-07       Impact factor: 5.996

8.  Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome.

Authors:  Mario Masellis; Parastoo Momeni; Wendy Meschino; Reid Heffner; Joshua Elder; Christine Sato; Yan Liang; Peter St George-Hyslop; John Hardy; Juan Bilbao; Sandra Black; Ekaterina Rogaeva
Journal:  Brain       Date:  2006-10-09       Impact factor: 13.501

9.  Exome sequencing reveals a novel partial deletion in the progranulin gene causing primary progressive aphasia.

Authors:  Jonathan D Rohrer; Jonathan Beck; Vincent Plagnol; Elizabeth Gordon; Tammaryn Lashley; Tamas Revesz; John C Janssen; Nick C Fox; Jason D Warren; Martin N Rossor; Simon Mead; Jonathan M Schott
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-07-31       Impact factor: 10.154

10.  Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival.

Authors:  Philip Van Damme; Annelies Van Hoecke; Diether Lambrechts; Peter Vanacker; Elke Bogaert; John van Swieten; Peter Carmeliet; Ludo Van Den Bosch; Wim Robberecht
Journal:  J Cell Biol       Date:  2008-03-31       Impact factor: 10.539

View more
  2 in total

1.  Lysosomal Dysfunction and Other Pathomechanisms in FTLD: Evidence from Progranulin Genetics and Biology.

Authors:  Xiaolai Zhou; Thomas Kukar; Rosa Rademakers
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Extended FTLD pedigree segregating a Belgian GRN-null mutation: neuropathological heterogeneity in one family.

Authors:  Anne Sieben; Sara Van Mossevelde; Eline Wauters; Sebastiaan Engelborghs; Julie van der Zee; Tim Van Langenhove; Patrick Santens; Marleen Praet; Paul Boon; Marijke Miatton; Sofie Van Hoecke; Mathieu Vandenbulcke; Rik Vandenberghe; Patrick Cras; Marc Cruts; Peter Paul De Deyn; Christine Van Broeckhoven; Jean-Jacques Martin
Journal:  Alzheimers Res Ther       Date:  2018-01-22       Impact factor: 6.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.